Sanofi

Sanofi

Posted via Workday

Wayrilz ITP Brand Manager

Apply by Oct 31, 2026

Posted Sep 3, 2026

Role at a glance

Job function
Marketing & Communications Brand Marketing
Salary
Not Disclosed
Location
Tokyo, Japan
Work arrangement
On-site
Employment
Full-time

Spotted an issue?

We’ll check it against the original posting.

Log in to report

About the role

Original posting provided by Sanofi

View original

Job title: Wayrilz ITP Brand Manager

  • Location: Tokyo 

About the job

IMH (Immune-Mediated Hematology) Marketing Group, Wayrilz ITP Brand Manager

Background)

At RBD franchise, we are serving people with intractable rare blood disorders by delivering innovative therapies and additional values. Within the franchise, IMH marketing is responsible for managing two brands which are, in-market brand Cablivi (for the treatment of aTTP/iTTP), and pre-launch brand Wayrilz (for ITP).

Wayrilz is a first-in-class & best-in-class BTK inhibitor for the treatment of ITP which has been approved by PMDA in June 2026. Wayrilz is a strategically prioritized product within the Specialty Care Business Unit also known as one of the Big 12. In addition to ITP, there are also other indications currently under development.

The mission of Wayrilz Brand Manager is to contribute to patients with ITP and associates and co-working with internal/external partners, including global brand team, to jointly create strategy, and execute tactical plans which are aligned with the strategy.

For the successful launch of Wayrilz in ITP, massive market shaping is critical in terms of transforming the way HCPs views and treats the condition, while empowering patients to seek for better QoL.

Hence, this is an exciting opportunity for those who are willing to delivering meaningful value for the society and aiming to grow his or her career through such job experience.

 

IMH ; immune-mediated hematology, aTTP/iTTP ; acquired/immune thrombotic thrombocytopenic purpura, ITP ; immune thrombocytopenia

 

Role and Responsibility)

・Having patient-centricity as the foundation, develop and execute well-defined winning brand plan.

・Launch preparation regarding material creation, and event management

・Collaborate with global brand team with “glocal” minds

・Co-work with other functions and external partners to ensure Sanofi being competitive against competitors' dynamism within the respective therapeutic area

 

About you

Qualification)

【Experience】

・>5 years experience in healthcare industry

・>3 years product marketing experience in pharma, creating marketing plan / forecast, deliverables (new product launch experience as a marketer in pharma preferred)

 

【Skill-set】

・Structured way of thinking with objective/fact based view point

・Collaborative team worker

・Going out of his/her comfort-zone to stretch themselves for development

 

【Languages】

・Fluency in Japanese (native level)

・Business level English to communicate with global team members

Pursue progress, discover extraordinary

Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.

At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!

Sanofi

About the company

Sanofi

Large Enterprise

Sanofi is a global healthcare leader committed to promoting health and well-being through the development of innovative medicines, vaccines, and therapeutic solutions. With a diverse portfolio that spans multiple therapeutic areas, including diabetes, oncology, and immunology, Sanofi is dedicated to addressing pressing health challenges and improving patient outcomes worldwide. Headquartered in France, the company employs over 100,000 individuals across more than 100 countries, fostering a culture of collaboration and scientific excellence to drive advancements in healthcare.